Bio-Techne (TECH) Financial Analysis & Valuation | Quarter Chart

Bio-Techne (TECH)

TECH
Price: $70.9
Fair Value: 🔒
🔒score
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life science reagents, instruments, and services for the research and clinical diagnostic markets worldwide. The company operates through two segments, Protein Sciences, and Diagnostics and Genomics. The Protei... more
Bio-Techne Corporation, together with its subsidiaries, develops, manufactures, and sells life scien... more
Description Shares
Market Cap$11.10BExchangeNASDAQ
SectorHealthcareIndustryBiotechnology
CountryUSCEOKim Kelderman
IPO Date1989-02-09CAGR0.14%
Employees3,100Websitewww.bio-techne.com
Div. Yield0.31%Payout Ratio0.45%
Buy Back Yield0.61%Total Yield0.92%
TECH chart loading...
Fundamentals Technicals
Enterprise Value$11.75BP/E Ratio36.55
Forward P/E34.6PEG Ratio0.79
P/S Ratio13.43P/B Ratio7.76
P/CF Ratio54.89P/FCF Ratio60.3
EPS$1.94EPS Growth 1Y-15.85%
EPS Growth 3Y-58.68%EPS Growth 5Y-40%
Revenue Growth 1Y0.17%Gross Margin0.65%
Operating Margin0.13%Profit Margin0.09%
ROE0.05%ROA0.04%
ROCE0.06%Current Ratio4.49
Quick Ratio3.18Cash Ratio1.37
Debt/Equity0.14Interest Coverage14.64
Altman Z Score15.83Piotroski Score8

View Bio-Techne financial charts →